Short‐acting β(2)‐agonist use and asthma exacerbations in Swedish children: A SABINA Junior study

BACKGROUND: In adults and adolescents with asthma, use of ≥3 short‐acting β(2)‐agonist (SABA) canisters/year is associated with increased exacerbation risk. Whether this association is present in younger children remains unknown. In this SABA use IN Asthma (SABINA) Junior study, we assessed the asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Melén, Erik, Nwaru, Bright I., Wiklund, Fredrik, de Fine Licht, Sofie, Telg, Gunilla, Maslova, Ekaterina, van der Valk, Ralf J. P., Tran, Trung N., Ekström, Magnus, Janson, Christer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828275/
https://www.ncbi.nlm.nih.gov/pubmed/36433853
http://dx.doi.org/10.1111/pai.13885